You are here

Press Releases

March 21, 2018
WASHINGTON, D.C. - AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that focuses on the value diagnostics bring to patients' health and health care, while addressing the need for regulatory modernization of the... Read More
January 18, 2018
GENEVA, SWITZERLAND – Today, the AMR Industry Alliance launches its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR). The Alliance brings together over 100... Read More
December 7, 2017
Diagnostics Industry Welcomes New Leader WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) which promotes innovation in diagnostic test technology, today announced the appointment of Susan Van Meter,... Read More
September 25, 2017
WASHINGTON, D.C. – AdvaMedDx released the following statement from Executive Director Andy Fish on CMS's recently issued preliminary lab payment amounts for 2018: "Diagnostic tests provide incredible value to the U.S health care system. These tests... Read More
April 6, 2017
Outgoing Chair John Bishop praised for work on passage of Protecting Access to Medicare Act and ongoing work on diagnostic regulatory reform Washington, D.C. – AdvaMedDx today announced that Hologic Chief Operating Officer Eric Compton has been... Read More
March 28, 2017
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, and chief strategy officer of AdvaMed, today issued the following statement regarding release of a discussion draft of the Diagnostic Accuracy and Innovation Act (DAIA) in the U.S.... Read More
January 20, 2017
New Framework Provides Recommendations for Optimizing Diagnostic Solutions to Combat AMR Davos-Klosters, Switzerland – AdvaMedDx, the association representing manufacturers of diagnostic tests to promote wellness, improve patient outcomes, and... Read More
November 21, 2016
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, today issued the following statement regarding FDA’s decision not to release at this time a final guidance on oversight of laboratory developed tests: “AdvaMedDx is disappointed that... Read More
October 17, 2016
WASHINGTON, DC – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), and Andy Fish, executive director of AdvaMedDx, today jointly issued the following statement on the Final Report of the Cancer Moonshot Task... Read More
September 20, 2016
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, issued the following statement on today’s Senate HELP Committee hearing on laboratory testing in the era of precision medicine: “AdvaMedDx commends the Senate HELP Committee for... Read More

Pages